MCT-Congress, which is dedicated to the business of mobile technology in the clinical trial space, has unveiled its eagerly anticipated conference programme for 2015. The two day congress, which will take place at the Edinburgh International Conference Centre (EICC), 24th-25th March 2015, will focus on the practicalities of adopting mobile technology in clinical trials. Looking at the field from all perspectives, from patient right through to sponsor, the programme is set to challenge norms and offer ideas as to how the mobile industry can increase its speed of integration within the clinical trials space.

Sponsored by Medidata, the congress brings together a community of providers, sponsors, academics, investigators and regulators, all with a shared goal of fostering innovation and collaboration that will take the industry forward in the adoption of mobile technology. Providing a global platform to raise the level of discussion in this fast-moving field, the congress will deliver a dynamic and energetic programme of speaker sessions, Q&As and panel discussions, including, among others:

  • The Real Business of Clinical Trials: A frank discussion amongst representatives from some of the biggest names in the industry about their business outlook and the forecasted influence of mobile technology. Oliver Stokes from Chiltern will be joined by peers from PPD, Quintiles and Clintec.
  • Device Design: Matt Kibby from BBK Worldwide will team-up with experts from Ericsson, Vodafone and Apple to discuss how intelligent design can provide transformational benefits in compliance, productivity and accuracy in clinical trials.
  • Barriers to Adoption: A panel discussion amongst some the industry’s leading experts, including Eli Lilly, Novartis, Merck and Janssen, will look at the challenges that big pharma is currently faced with and drivers in speeding up long-term adoption of mobile.
  • Cautionary Tales of Data Mountains: Marc Buyse from IDDI & CluePoints will discuss the importance of ensuring data quality in clinical trials that use mobile technology, delivering new thinking in how successful monitoring strategies can be approached.
  • Effective Regulator Relations: Pfizer’s Craig Lipset will offer a thought-provoking session on how the industry can best work with regulators to ensure successful development programmes.
  • Realities of On-site Adoption: A group of highly-experienced data professionals from Bayer, the NHS and ICON will deliver a 360 degree perspective on managing data mountains.

“The 2015 MCT-Congress programme has been designed to deliver the highest quality speakers and leading-edge industry discussion, promoting understanding and collaboration that will help shape the direction of mobile in clinical trials”, commented Liz Logan, Head of the MCT-Congress. “The event provides a unique and unbiased space to meet new people from around the world, spark genuine debate, share knowledge, network and build relationships that change the future of clinical development.”



To see the full programme outline and register for a place, please visit or call +44(0)7866 782165

Join the discussion on Twitter using #MCTCongress